首頁 › 乳癌 › 佛羅里達 › Plantation
Plantation, FL 的 乳癌 臨床試驗
14 項針對 乳癌 的研究正在 Plantation（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
招募中3 期
- Research Site, Plantation
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
招募中3 期
- Miami Cancer Institute, Plantation
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
招募中3 期
- Miami Cancer Institute at Plantation, Plantation
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
招募中3 期
- University of Miami-SCCC-Plantation, Plantation
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
招募中3 期
- Miami Cancer Institute at Plantation, Plantation
- UM Sylvester Comprehensive Cancer Center at Plantation, Plantation
ATEMPT 2.0: Adjuvant T-DM1 vs TH
招募中2 期
- Miami Cancer Institute - Plantation (MCIP), Plantation
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
招募中3 期
- UM Sylvester Comprehensive Cancer Center at Plantation, Plantation
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
招募中3 期
- Miami Cancer Institute Plantation, Plantation
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
招募中3 期
- BRCR Medical Center, Inc- Internal Medicine, Plantation
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
招募中2 期
- Miami Cancer Institute at Baptist Health, Plantation
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
招募中3 期
- UM Sylvester Comprehensive Cancer Center at Plantation, Plantation
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
招募中1 期
- BRCR Global, Plantation
- Florida Clinical Trials Group, Plantation
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
招募中1/2 期
- BRCR global, Plantation
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
招募中觀察性研究
- Baptist Cancer Care - Plantation, Plantation
其他城市的 乳癌 試驗
- New York City, NY136 項研究
- Houston, TX126 項研究
- Boston, MA112 項研究
- Nashville, TN81 項研究
- Los Angeles, CA73 項研究
- Edison, NJ68 項研究
- St. Louis, MO64 項研究
- Queens, NY64 項研究
- Durham, NC64 項研究
- Chicago, IL59 項研究
- Philadelphia, PA56 項研究
- Dallas, TX55 項研究
Plantation 的其他研究
- 非小細胞肺癌16 項研究
- 癌症（所有類型）7 項研究
- 紅斑性狼瘡7 項研究
- 肺癌7 項研究
- 轉移性癌症6 項研究
- 類風濕性關節炎6 項研究
- 前列腺癌5 項研究
- 牛皮癬關節炎5 項研究
- 大腸直腸癌5 項研究
- 黑色素瘤4 項研究
- 多發性骨髓瘤4 項研究
- 小細胞肺癌4 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。